Xeltis
Alexander Goemans joined Xeltis as Chief Financial Officer in November 2021. He brings to the company significant experience in strategy consulting, and investment and financial management, during which he completed numerous acquisitions, equity raises and financings.
Prior to Xeltis, Alexander served as CFO of miDiagnostics, a molecular diagnostics company, and Victrix, an investment holding with €300 million of assets under management.
He started his career as a strategy consultant at McKinsey & Co, where he focused on M&A and private equity topics across a wide range of industries and geographies. Alexander obtained a MSc in Business Engineering from KULeuven and a MSc in Finance from the London School of Economics.
This person is not in any offices
Xeltis
Xeltis is a clinical-stage medical device company leveraging breakthrough science to transform heart valve therapy.